美迪西：股东提前终止减持计划暨减持股份结果公告

Core Viewpoint - MediXis announced that shareholder Chen Guoxing has terminated the share reduction plan ahead of schedule, which was originally set to reduce up to 2,200,000 shares (1.64% of total share capital) between December 11, 2025, and March 10, 2026. The actual reduction did not occur, and Chen Guoxing continues to hold 4,875,154 shares, representing 3.63% of the total shares [1]. Summary by Category - Shareholder Actions - Chen Guoxing has decided to terminate the planned share reduction, which was set to occur over a specified future period [1]. - The planned reduction was for a maximum of 2,200,000 shares, equating to 1.64% of the total share capital [1]. - As of now, Chen Guoxing retains 4,875,154 shares, which is 3.63% of the total shares outstanding [1].